Orthocell Ltd Net Assets

Latest as of June 2025: AU$14.57 Million AUD ≈ $10.31 Million USD

Orthocell Ltd net assets. Based on the latest financial reports, Orthocell Ltd (OCC) has net assets worth AU$14.57 Million AUD (≈ $10.31 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$35.24 Million ≈ $24.93 Million USD) and total liabilities (AU$20.67 Million ≈ $14.62 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Orthocell Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$14.57 Million
% of Total Assets	41.35%
Annual Growth Rate	17.41%
5-Year Change	-13.66%
10-Year Change	198.26%
Growth Volatility	1452.83

Net Assets of Orthocell Ltd (2010–2025)

Net assets of Orthocell Ltd from 2010 to 2025. This chart illustrates how Orthocell Ltd's net assets have evolved over time, based on quarterly financial data. See Orthocell Ltd balance sheet quality to measure how much of total assets are equity-financed.

Annual Net Assets for Orthocell Ltd (2010–2025)

The table below shows the annual net assets of Orthocell Ltd from 2010 to 2025. For live market cap and overall valuation, see Orthocell Ltd (OCC) market capitalisation.

Year	Net Assets	Change
2025-06-30	AU$14.57 Million ≈ $10.31 Million	+221.43%
2024-06-30	AU$4.53 Million ≈ $3.21 Million	-26.29%
2023-06-30	AU$6.15 Million ≈ $4.35 Million	-37.92%
2022-06-30	AU$9.90 Million ≈ $7.01 Million	-41.30%
2021-06-30	AU$16.87 Million ≈ $11.94 Million	-19.27%
2020-06-30	AU$20.90 Million ≈ $14.79 Million	+94.91%
2019-06-30	AU$10.72 Million ≈ $7.59 Million	+352.09%
2018-06-30	AU$2.37 Million ≈ $1.68 Million	-49.66%
2017-06-30	AU$4.71 Million ≈ $3.33 Million	-3.52%
2016-06-30	AU$4.88 Million ≈ $3.46 Million	+11.42%
2015-06-30	AU$4.38 Million ≈ $3.10 Million	+5653.91%
2014-06-30	AU$76.19K ≈ $53.91K	-92.93%
2013-06-30	AU$1.08 Million ≈ $762.57K	-31.18%
2011-06-30	AU$1.57 Million ≈ $1.11 Million	+19.36%
2010-06-30	AU$1.31 Million ≈ $928.32K	--

Equity Component Analysis

This analysis shows how different components contribute to Orthocell Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 7407040200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Orthocell Ltd Net Assets Breakdown (June 2025)

Orthocell Ltd net assets breakdown by equity component as of June 2025.

Component	Amount	Percentage
Common Stock	AU$83.49 Million	573.05%
Other Comprehensive Income	AU$5.15 Million	35.37%
Total Equity	AU$14.57 Million	100.00%

Orthocell Ltd Competitors by Market Cap

The table below lists competitors of Orthocell Ltd ranked by their market capitalization.

Company	Market Cap
San Lien Technology TWO:5493	$109.43 Million
Humanica Public Company Limited BK:HUMAN	$109.47 Million
Minerva Neurosciences Inc NASDAQ:NERV	$109.48 Million
Besiktas Futbol Yatirimlari Sanayi ve Ticaret AS IS:BJKAS	$109.49 Million
Noroo Paint KO:090350	$109.38 Million
Graphite One Inc V:GPH	$109.31 Million
Nelly Group AB ST:NELLY	$109.31 Million
Avaco Co. Ltd KQ:083930	$109.30 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Orthocell Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 4,532,574 to 14,568,834, a change of 10,036,260 (221.4%).
Net loss of 8,566,640 reduced equity.
Share repurchases of 882,000 reduced equity.
Other comprehensive income decreased equity by 2,786,311.
Other factors increased equity by 22,271,211.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-8.57 Million	-58.8%
Share Repurchases	AU$882.00K	-6.05%
Other Comprehensive Income	AU$-2.79 Million	-19.13%
Other Changes	AU$22.27 Million	+152.87%
Total Change	AU$-	221.43%

Book Value vs Market Value Analysis

This analysis compares Orthocell Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 8.73x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 92.05x to 8.73x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-06-30	AU$0.01	AU$0.57	x
2014-06-30	AU$0.00	AU$0.57	x
2015-06-30	AU$0.06	AU$0.57	x
2016-06-30	AU$0.06	AU$0.57	x
2017-06-30	AU$0.05	AU$0.57	x
2018-06-30	AU$0.02	AU$0.57	x
2019-06-30	AU$0.09	AU$0.57	x
2020-06-30	AU$0.12	AU$0.57	x
2021-06-30	AU$0.09	AU$0.57	x
2022-06-30	AU$0.05	AU$0.57	x
2023-06-30	AU$0.03	AU$0.57	x
2024-06-30	AU$0.02	AU$0.57	x
2025-06-30	AU$0.07	AU$0.57	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Orthocell Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -58.80%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -113.46%
• Asset Turnover: 0.21x
• Equity Multiplier: 2.42x
Recent ROE (-58.80%) is above the historical average (-348.07%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	-618.14%	-252.41%	0.30x	8.24x	AU$-1.34 Million
2014	-2864.21%	-315.62%	0.13x	67.44x	AU$-2.19 Million
2015	-85.38%	-473.50%	0.12x	1.49x	AU$-4.18 Million
2016	-77.49%	-567.87%	0.09x	1.46x	AU$-4.27 Million
2017	-88.65%	-788.46%	0.07x	1.52x	AU$-4.65 Million
2018	-242.69%	-929.80%	0.12x	2.20x	AU$-5.99 Million
2019	-54.57%	-618.85%	0.07x	1.27x	AU$-6.92 Million
2020	-29.43%	-854.88%	0.03x	1.11x	AU$-8.24 Million
2021	-53.55%	-887.76%	0.05x	1.15x	AU$-10.72 Million
2022	-91.94%	-594.53%	0.04x	3.83x	AU$-10.10 Million
2023	-101.61%	-147.26%	0.14x	4.81x	AU$-6.86 Million
2024	-158.43%	-135.10%	0.20x	5.87x	AU$-7.63 Million
2025	-58.80%	-113.46%	0.21x	2.42x	AU$-10.02 Million

Industry Comparison

This section compares Orthocell Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $9,148,619
Average return on equity (ROE) among peers: -291.43%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Orthocell Ltd (OCC)	AU$14.57 Million	-618.14%	1.42x	$109.42 Million
Adalta Ltd (1AD)	$705.89K	-185.28%	0.37x	$3.61 Million
Algorae Pharmaceuticals Ltd (1AI)	$1.40 Million	-427.26%	1.72x	$12.88 Million
ACRUX Ltd (ACR)	$43.89 Million	29.58%	0.22x	$2.91 Million
Actinogen Medical Ltd (ACW)	$1.90 Million	-48.73%	0.06x	$92.21 Million
Argenica Therapeutics Ltd (AGN)	$18.40K	-2084.05%	19.53x	$10.45 Million
Arovella Therapeutics Ltd (ALA)	$13.35 Million	-1.99%	0.25x	$42.76 Million
Anatara Lifesciences Ltd (ANR)	$3.83 Million	-52.11%	0.13x	$1.40 Million
Alterity Therapeutics Ltd (ATH)	$15.78 Million	-28.97%	0.04x	$108.75 Million
Amplia Therapeutics Ltd (ATX)	$6.07 Million	-40.21%	0.29x	$30.51 Million
Avecho Biotechnology Ltd (AVE)	$4.54 Million	-75.30%	0.16x	$35.54 Million

About Orthocell Ltd

AU:OCC Australia Biotechnology

Market Cap

$109.42 Million

AU$154.65 Million AUD

Market Cap Rank

#18643 Global

#577 in Australia

Share Price

AU$0.57

Change (1 day)

+0.00%

52-Week Range

AU$0.50 - AU$1.15

All Time High

AU$1.75